Skip to search formSkip to main contentSkip to account menu

olodaterol

Known as: 6-hydroxy-8-(1-hydroxy-2-((2-(4-methoxyphenyl)-1,1-dimethylethyl)amino)ethyl)-2H-1,4-benzoxazin-3(4H)-one 
National Institutes of Health

Related topics

Related topics

8 relations
28 ACTUAT olodaterol 0.0025 MG/ACTUAT Metered Dose Inhaler [Striverdi]60 ACTUAT olodaterol 0.0025 MG/ACTUAT / tiotropium 0.0025 MG/ACTUAT Metered Dose InhalerAdrenergic beta2-Agonists [MoA]olodaterol / tiotropium

Broader (3)

Adrenergic beta-1 Receptor AgonistsBenzoxazinesBronchodilator Agents

Narrower (1)

Olodaterol hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
[Current position of new fixed-dose combination of tiotropium and olodaterol - its role in the treatment of chronic obstructive pulmonary disease in the Czech Republic].
COPD is a serious pulmonary disease with rising global socioeconomic impact. From the perspective of the Czech Republic COPD was… 
2018
2018
Клиническая и фармакоэкономическая оценка применения комбинации тиотропия бромида и олодатерола у пациентов с хронической обструктивной болезнью легких
The paper is devoted to the problem of clinical efficacy and pharmacoeconomic evaluation of Spiolto Respimat. The results of… 
2018
2018
Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study
2016
2016
S34 Effect of 8 and 12 weeks’ once-daily tiotropium and olodaterol, alone and combined with exercise training, on exercise endurance during walking in patients with copd
T Troosters has received grants from Innovative Medicines Initiative Joint Undertaking and speaker fees from Boehringer Ingelheim… 
2016
2016
S34 Effect of 8 and 12 weeks’ once-daily tiotropium and olodaterol, alone and combined with exercise training, on exercise endurance during walking in patients with copd
Rationale Physical deconditioning is common in patients with chronic obstructive pulmonary disease (COPD), limiting exercise… 
2016
2016
Pooled Safety Analysis Of Adjudicated Serious Adverse Events With The Fixed-Dose Combination Of Tiotropium + Olodaterol
2015
2015
Safety of once-daily tiotropium and olodaterol fixed-dose combination via the respimat in chronic obstructive pulmonary disease in two 1-year studies
2012
2012
Tiotropium enhances the inhibitory effect of the long acting β2-agonist olodaterol on the release of IL-6 and IL8 by primary human lung fibroblasts of asthma patients
Muscarinic and β2-adrenergic receptors of resident lung cells are modulators of airway inflammation and remodeling. Here, we used… 
2012
2012
Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD
printing supported by . Visit Chiesi at Stand B2.10 MONDAY, SEPTEMBER 3RD 2012 correlated with the production of IL-8. In acute… 
1984
1984
“FDA-approved” indications